"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Deke Slayton Cancer Center Deke Slayton Cancer Center (2) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Deke Slayton Cancer Center Deke Slayton Cancer Center (2)" are "Hematologic Malignancies" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials), "Solid Tumor" (1 trials) and "Solid Tumor and Hematologic Malignancies" (1 trials). Many other conditions were trialed in "Deke Slayton Cancer Center Deke Slayton Cancer Center (2)" in a lesser frequency.

Most popular intervention types in "Deke Slayton Cancer Center Deke Slayton Cancer Center (2)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "BGJ398" (1 trials), "Dovitinib" (1 trials), "MEK162" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deke Slayton Cancer Center Deke Slayton Cancer Center (2)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Deke Slayton Cancer Center Deke Slayton Cancer Center (2)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Deke Slayton Cancer Center Deke Slayton Cancer Center (2), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Deke Slayton Cancer Center Deke Slayton Cancer Center (2), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".